DPSI yields 19.56% · JNJ yields 2.14%● Live data
📍 DPSI pulled ahead of the other in Year 1
Combined, DPSI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DPSI + JNJ for your $10,000?
Decisionpoint Systems, Inc. provides and integrates enterprise mobility and wireless applications solutions that delivers improved productivity and operational advantages to its clients by helping to move business decision points closer to its customers. It makes enterprise software applications accessible to the front-line worker anytime, anywhere. The company utilizes wireless, mobility, and RFID technologies. It sells, installs, deploys, and repairs mobile computing and wireless systems, such as mobile computers and application software; and related data capture equipment, including bar code scanners and radio frequency identification readers for the retail, warehousing and distribution, healthcare, wholesale distribution, and field sales and service industries. The company also offers lifecycle management, and project management and deployment services; and managed services, such as consulting, technology acquisition, project management, software integration and development, deployment, repair services, service desk, and reverse logistics and end of life disposal services, as well as OnPoint Service Hub, a customer service portal that provides customers real-time asset management and tracking information. In addition, it provides MobileConductor, a software platform that provides complete in-vehicles solutions; VizeTrace, a software platform that manages RFID installations; and custom software development services, as well as resells specialized independent software vendors applications. The company is headquartered in Laguna Hills, California.
Full DPSI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.